Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (1): 47-52.doi: 10.3969/j.issn.1000-6621.2018.01.012
• Original Articles • Previous Articles Next Articles
Song YANG,Xiao-feng YAN,Xiao-gang ZENG,Shun TAN,Jian-qiong. GUO()
Received:
2017-09-03
Online:
2018-01-10
Published:
2018-03-14
Song YANG,Xiao-feng YAN,Xiao-gang ZENG,Shun TAN,Jian-qiong. GUO. Evaluation of the serodiagnostic value by using tuberculosis antibody test in diagnosis of active pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2018, 40(1): 47-52. doi: 10.3969/j.issn.1000-6621.2018.01.012
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.01.012
抗体组合 | 观察组患者(340例) | 对照组患者(55例) | ||
---|---|---|---|---|
阳性值 | 合计 | 阳性值 | 合计 | |
单一抗体 | ||||
IgG | 35(10.3) | 37(10.9) | 37(67.3) | 37(67.3) |
IgM | 2(0.6) | 0(0.0) | ||
2种抗体 | ||||
IgG+IgM | 0(0.0) | 63(18.5) | 2(3.6) | 4(7.2) |
LAM+16kD | 1(0.3) | 0(0.0) | ||
IgG+16kD | 5(1.5) | 0(0.0) | ||
LAM+38kD | 57(16.7) | 2(3.6) | ||
3种抗体 | ||||
LAM+38kD+IgG | 210(61.8) | 219(64.4) | 14(25.5) | 14(25.5) |
LAM+38kD+IgM | 5(1.5) | 0(0.0) | ||
16kD+IgM+IgG | 4(1.2) | 0(0.0) | ||
4种抗体 | ||||
LAM+38kD+16kD+IgG | 21(6.2) | 21(6.2) | 0(0.0) | 0(0.0) |
[1] | World Health Organization . Global tuberculosis report 2017. Geneva: World Health Organization, 2017. |
[2] |
Zhao J, Matsuba T, Zhang X , et al. Comparison of antibody responses against Mycobacterium tuberculosis antigen Rv0679c in tuberculosis patients from the endemic and non-endemic regions of the Beijing genotype: a case control study. BMC Infect Dis, 2017,17(1):344.
doi: 10.1186/s12879-017-2442-5 URL |
[3] |
Wang Y, Lu B, Liu J , et al. A multicenter clinical evaluation of Mycobacterium tuberculosis IgG/IgM antibody detection using the colloidal gold method. Eur J Clin Microbiol Infect Dis, 2014,33(11):1989-1994.
doi: 10.1007/s10096-014-2150-7 URL |
[4] |
Guenaoui K, Harir N, Ouardi A , et al. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of ri-fampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases. Ann Transl Med, 2016,4(9):168.
doi: 10.21037/atm URL |
[5] | World Health Organization . WHO treatment guidelines for drug-resistant tuberculosis. Geneva:World Health Organization, 2016. |
[6] | 中华人民共和国卫生部. 肺结核诊断标准(WS 288-2008) . 北京: 人民卫生出版社, 2008. |
[7] |
杜秀然, 李春霞, 刘锐 , 等. 结核生物蛋白芯片技术对肺结核的诊断价值. 河北医药, 2015,37(1):40-42.
doi: 10.3969/j.issn.1002-7386.2015.01.012 URL |
[8] |
Liu C, Zhao Z, Fan J , et al. Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring. Proc Natl Acad Sci U S A, 2017,114(15):3969-3974.
doi: 10.1073/pnas.1621360114 URL |
[9] | World Health Organization . XpertMTB/RIF:WHO Policy Update and Implementation Manual 2014. Geneva:World Health Organization, 2014. |
[10] | Mazurek GH, Jereb J, Vernon A , et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States,2010. MMWR Recomm Rep, 2010,59(RR-5):1-25. |
[11] |
Khurshid S, Afzal M, Khalid R , et al. Potential of multi-component antigens for tuberculosis diagnosis. Biologicals, 2017,48:109-113.
doi: 10.1016/j.biologicals.2017.04.004 URL pmid: 28522247 |
[12] |
Sankar MM, Balooni V, Singh J , et al. Diagnostic performance of commercially available enzyme-linked immunosorbent assay kit in the diagnosis of extrapulmonary tuberculosis. J Lab Physicians, 2013,5(1):11-16.
doi: 10.4103/0974-2727.115902 URL |
[13] |
Feng X, Yang X, Xiu B , et al. IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis. BMC Infect Dis, 2014,14:336.
doi: 10.1186/1471-2334-14-336 URL pmid: 24939009 |
[14] | Awoniyi DO, Baumann R, Chegou NN , et al. Detection of a combination of serum IgG and IgA antibodies against selected mycobacterial targets provides promising diagnostic signatures for active TB. Oncotarget, 2017,8(23):37525-37537. |
[15] | Takenami I, de Oliveira CC, Lima FR , et al. Immunoglobulin G response to mammalian cell entry 1A (Mce1A) protein as biomarker of active tuberculosis. Tuberculosis(Edinb), 2016,100:82-88. |
[16] |
Zhao N, Sun JY, Xu HP , et al. Early diagnosis of tuberculosis-associated IgA nephropathy with ESAT-6. Tohoku J Exp Med, 2017,241(4):271-279.
doi: 10.1620/tjem.241.271 URL |
[17] |
Diouani MF, Ouerghi O, Refai A , et al. Detection of ESAT-6 by a label free Miniature immuno-electrochemical biosensor as a diagnostic tool for tuberculosis. Mater Sci Eng C Mater Biol Appl, 2017,74:465-470.
doi: 10.1016/j.msec.2016.12.051 URL |
[18] |
Tebianian M, Mosavari N, Taghizadeh M , et al. Evaluation of specific antibodies against Mycobacterium Tuberculosis recombinant antigens for detection of recent infection. Int J Mycobacteriol , 2016,5 Suppl 1: S254.
doi: 10.1016/j.ijmyco.2016.11.011 URL |
[19] |
Pathakumari B, Prabhavathi M, Anbarasu D , et al. Dynamic IgG antibody response to immunodominant antigens of M.tuberculosis for active TB diagnosis in high endemic settings. Clin Chim Acta, 2016,461:25-33.
doi: 10.1016/j.cca.2016.06.033 URL |
[20] |
Senoputra MA, Shiratori B, Hasibuan FM , et al. Diagnostic value of antibody responses to multiple antigens from Mycobacterium tuberculosis in active and latent tuberculosis. Diagn Microbiol Infect Dis, 2015,83(3):278-285.
doi: 10.1016/j.diagmicrobio.2015.07.021 URL |
[21] |
Raju R, Suneetha S, Sagili K , et al. Diagnostic role of the antibody response to the 38kDa, 16kDa proteins and lipoarabinomannan of mycobacterium tuberculosis. Indian J Clin Biochem, 2005,20(1):123-128.
doi: 10.1007/BF02893056 URL |
[22] |
Zagmignan A, Costa ACD, Viana JL , et al. Identification of specific antibodies against the Ag85C-MPT51-HspX fusion protein (CMX) for serological screening of tuberculosis in endemic area. Expert Rev Clin Immunol, 2017,13(8):837-843.
doi: 10.1080/1744666X.2017.1345626 URL |
[23] |
Liang Y, Zhang J, Yang Y , et al. Immunogenicity and therapeutic effects of recombinant Ag85AB fusion protein vaccines in mice infected with Mycobacterium tuberculosis. Vaccine, 2017,35(32):3995-4001.
doi: 10.1016/j.vaccine.2017.05.083 URL |
[24] |
Broger T, Basu Roy R, Filomena A , et al. Diagnostic perfor-mance of tuberculosis-specific IgG antibody profiles in patients with presumptive tuberculosis from two continents. Clin Infect Dis, 2017,64(7):947-955.
doi: 10.1093/cid/cix023 URL |
[25] |
Aliannejad R, Bahrmand A, Abtahi H , et al. Accuracy of a new rapid antigen detection test for pulmonary tuberculosis. Iran J Microbiol, 2016,8(4):238-242.
URL pmid: 28210462 |
[26] |
Shakibamehr N, Mosavari N, Babaie M , et al. Evaluate the efficiency of Antigen 60 ( A60)protein from BCG strain of Mycobacterium bovis as a diagnostic antigen.Int J Mycobacteriol, 2016,5 Suppl 1: S226-227.
doi: 10.1016/j.ijmyco.2016.10.022 URL |
[27] |
Yari S, HadizadehTasbiti A, Ghanei M , et al. Proteome-scale MDR-TB-antibody responses for identification of putative biomarkers for the diagnosis of drug-resistant Mycobacterium tuberculosis.Int J Mycobacteriol, 2016,5 Suppl 1: S134-135.
doi: 10.1016/j.ijmyco.2016.10.011 URL |
[28] |
Gupta AK, Srivastava S, Singh A , et al. Development of rapid immuno-diagnostic test for the early detection of tuberculosis. Int J Mycobacteriol, 2016,5 Suppl 1: S114-115.
doi: 10.1016/j.ijmyco.2016.11.008 URL pmid: 28043495 |
[29] |
Li JL, Huang XY, Chen HB , et al. Simultaneous detection of IgG and IgM antibodies against a recombinant polyprotein PstS1-LEP for tuberculosis diagnosis. Infect Dis (Lond), 2015,47(9):643-649.
doi: 10.3109/23744235.2015.1043941 URL |
[30] |
Zhou F, Xu X, Wu S , et al. Influence of HLA-DRB1 alleles on the variations of antibody response to tuberculosis serodiagnostic antigens in active tuberculosis patients,2016. PLoS One, 2016,11(10):e0165291.
doi: 10.1371/journal.pone.0165291 URL |
[31] |
Valentini D, Rao M, Ferrara G , et al. Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays. Int J Infect Dis, 2017,56:155-166.
doi: 10.1016/j.ijid.2017.01.015 URL |
[32] | Zhao J, Shiratori B, Okumura M , et al. Difference in antibody responses to Mycobacterium tuberculosis antigens in Japanese tuberculosis patients infected with the Beijing/non-Beijing Genotype. J Immunol Res, 2017,2017:4797856 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||